375 related articles for article (PubMed ID: 19441719)
1. [Therapeutic effect and pharmacokinetics of transdermal phenazepam preparation in patients with different anxiety disorders].
Dorofeeva OA; Siuniakov SA; Zherdev VP; Kolyvanov GB; Litvin AA; Neznamov GG
Eksp Klin Farmakol; 2009; 72(2):6-10. PubMed ID: 19441719
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacokinetics and efficacy of phenazepam after transdermal and enteral administration in rats].
Zherdev VP; Voronina TA; Garibova TL; Kolyvanov GB; Litvin AA; Sariev AK; Tokhmakhchi VN; Vasil'ev AE
Eksp Klin Farmakol; 2003; 66(1):50-3. PubMed ID: 12683082
[TBL] [Abstract][Full Text] [Related]
3. The role of extended-release benzodiazepines in the treatment of anxiety: a risk-benefit evaluation with a focus on extended-release alprazolam.
Klein E
J Clin Psychiatry; 2002; 63 Suppl 14():27-33. PubMed ID: 12562116
[TBL] [Abstract][Full Text] [Related]
4. [Effect of phenazepam in various medicinal forms on psychophysical state of patients with anxiety disorders].
Neznamov GG; Dorofeeva OA; Teleshova ES; Siuniakov SA; Mametova LÉ
Eksp Klin Farmakol; 2011; 74(5):6-12. PubMed ID: 21809691
[TBL] [Abstract][Full Text] [Related]
5. Biokinetics of transdermal therapeutic medicinal form of phenazepam.
Golovenko NY; Kravchenko IA; Zin'kovskii VG; Andronati SA; Aleksandrova AI; Ovcharenko NV; Larionov VB
Bull Exp Biol Med; 2000 Dec; 130(12):1153-5. PubMed ID: 11276308
[TBL] [Abstract][Full Text] [Related]
6. [A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders].
Medvedev VE; Tereshchenko ON; Israelian AIu; Chobanu IK; Kost NV; Sokolov OIu; Miasoedov NF
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(7):17-22. PubMed ID: 25176261
[TBL] [Abstract][Full Text] [Related]
7. Anxiety disorders. Part 2: Pharmacotherapy with benzodiazepines.
Labelle A; Lapierre YD
Can Fam Physician; 1993 Oct; 39():2205-8; 2211-3. PubMed ID: 8106034
[TBL] [Abstract][Full Text] [Related]
8. [Experimental pharmacokinetics of phenazepam during transdermal administration of the therapeutic phenaperkuten system].
Litvin AA
Eksp Klin Farmakol; 2004; 67(2):59-62. PubMed ID: 15188765
[TBL] [Abstract][Full Text] [Related]
9. Switching from benzodiazepines to buspirone using a tapered overlap method in generalized anxiety disorder.
Arató M
J Clin Psychiatry; 2001 Aug; 62(8):657-8. PubMed ID: 11561943
[No Abstract] [Full Text] [Related]
10. [Clinical study of the selective anxiolytic agent afobazol].
Neznamov GG; Siuniakov SA; Chumakov DV; Bochkarev VK; Seredenin SB
Eksp Klin Farmakol; 2001; 64(2):15-9. PubMed ID: 11548440
[TBL] [Abstract][Full Text] [Related]
11. [Update on benzodiazepines].
Marino A; Costa R
Recenti Prog Med; 1992 May; 83(5):249-54. PubMed ID: 1359614
[TBL] [Abstract][Full Text] [Related]
12. The use of benzodiazepines in the aged patient: clinical and pharmacological considerations.
Dailly E; Bourin M
Pak J Pharm Sci; 2008 Apr; 21(2):144-50. PubMed ID: 18390445
[TBL] [Abstract][Full Text] [Related]
13. [Excerpts from the clinical-pharmacologic and clinical studies of Grandaxin].
Szegó J; Somogyi M; Papp E
Acta Pharm Hung; 1993 Mar; 63(2):91-8. PubMed ID: 8100114
[TBL] [Abstract][Full Text] [Related]
14. [Optimization of the treatment of anxiety disorders with selank].
Medvedev VE; Tereshchenko ON; Kost NV; Ter-Israelyan AY; Gushanskaya EV; Chobanu IK; Sokolov OY; Myasoedov NF
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(6):33-40. PubMed ID: 26356395
[TBL] [Abstract][Full Text] [Related]
15. Benzodiazepine discontinuation among adults with GAD: A randomized trial of cognitive-behavioral therapy.
Gosselin P; Ladouceur R; Morin CM; Dugas MJ; Baillargeon L
J Consult Clin Psychol; 2006 Oct; 74(5):908-19. PubMed ID: 17032095
[TBL] [Abstract][Full Text] [Related]
16. Benzodiazepines in clinical practice: consideration of their long-term use and alternative agents.
Stevens JC; Pollack MH
J Clin Psychiatry; 2005; 66 Suppl 2():21-7. PubMed ID: 15762816
[TBL] [Abstract][Full Text] [Related]
17. Anxiety states and benzodiazepines.
Tollefson G; Lesar T; Teubner-Rhodes D
Am Fam Physician; 1983 May; 27(5):151-8. PubMed ID: 6133442
[TBL] [Abstract][Full Text] [Related]
18. Attitudes toward benzodiazepines over the years.
Rosenbaum JF
J Clin Psychiatry; 2005; 66 Suppl 2():4-8. PubMed ID: 15762813
[TBL] [Abstract][Full Text] [Related]
19. Physician Withdrawal Checklist (PWC-20).
Rickels K; Garcia-Espana F; Mandos LA; Case GW
J Clin Psychopharmacol; 2008 Aug; 28(4):447-51. PubMed ID: 18626273
[TBL] [Abstract][Full Text] [Related]
20. Quazepam: a new hypnotic.
Med Lett Drugs Ther; 1990 Apr; 32(816):39-40. PubMed ID: 1970112
[No Abstract] [Full Text] [Related]
[Next] [New Search]
